HighVista Strategies »

Alumis shares owned by HighVista Strategies

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 113k 22.03

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Alumis

AyurMaya Capital Management Company
BlackRock
Deep Track Capital
Samsara BioCapital
Foresite Capital Management V
venBio Partners
Foresite Capital Management VI
Vanguard Group
Vanguard Capital Management
Cormorant Asset Management
Nextech Invest
Saturn V Capital Management
UBS Group
Octagon Capital Advisors
MPM Oncology Impact Management

View all funds holding Alumis